SVRA

Savara (SVRA)

Savara Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SVRA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/02/15	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2025/02/15	06 : 05	Business Wire	Savara Announces New Employment Inducement Grant	NASDAQ:SVRA	Savara Inc
2025/02/15	04 : 33	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:SVRA	Savara Inc
2025/02/12	07 : 14	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:SVRA	Savara Inc
2025/01/30	22 : 39	Business Wire	Savara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open Research	NASDAQ:SVRA	Savara Inc
2025/01/30	06 : 05	Business Wire	Savara Announces Participation in Upcoming Healthcare Investor Conferences	NASDAQ:SVRA	Savara Inc
2025/01/24	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SVRA	Savara Inc
2025/01/13	22 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SVRA	Savara Inc
2024/12/24	06 : 05	Business Wire	Savara Announces New Employment Inducement Grant	NASDAQ:SVRA	Savara Inc
2024/12/19	06 : 05	Business Wire	Savara Initiates Rolling Submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP)	NASDAQ:SVRA	Savara Inc
2024/12/18	06 : 05	Business Wire	Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:SVRA	Savara Inc
2024/12/17	08 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	08 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	08 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	07 : 13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	05 : 15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SVRA	Savara Inc
2024/12/17	05 : 08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SVRA	Savara Inc
2024/11/28	01 : 01	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:SVRA	Savara Inc
2024/11/23	06 : 05	Business Wire	Savara Announces New Employment Inducement Grant	NASDAQ:SVRA	Savara Inc
2024/11/22	22 : 05	Business Wire	Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the British Thoracic Society Winter Meeting 2024	NASDAQ:SVRA	Savara Inc
2024/11/20	21 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc
2024/11/19	02 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SVRA	Savara Inc